CN108883168A - 使用疫苗治疗癌症或皮肤病变的方法和组合物 - Google Patents
使用疫苗治疗癌症或皮肤病变的方法和组合物 Download PDFInfo
- Publication number
- CN108883168A CN108883168A CN201780016785.3A CN201780016785A CN108883168A CN 108883168 A CN108883168 A CN 108883168A CN 201780016785 A CN201780016785 A CN 201780016785A CN 108883168 A CN108883168 A CN 108883168A
- Authority
- CN
- China
- Prior art keywords
- hpv
- types
- vaccine
- dosage
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662300785P | 2016-02-27 | 2016-02-27 | |
US62/300,785 | 2016-02-27 | ||
US201662328487P | 2016-04-27 | 2016-04-27 | |
US62/328,487 | 2016-04-27 | ||
US201662338183P | 2016-05-18 | 2016-05-18 | |
US62/338,183 | 2016-05-18 | ||
US201762444576P | 2017-01-10 | 2017-01-10 | |
US62/444,576 | 2017-01-10 | ||
US201762455434P | 2017-02-06 | 2017-02-06 | |
US62/455,434 | 2017-02-06 | ||
PCT/US2017/019433 WO2017147475A1 (en) | 2016-02-27 | 2017-02-24 | Method and composition for treating cancer or skin lesion using a vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108883168A true CN108883168A (zh) | 2018-11-23 |
Family
ID=59686556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780016785.3A Pending CN108883168A (zh) | 2016-02-27 | 2017-02-24 | 使用疫苗治疗癌症或皮肤病变的方法和组合物 |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP3419661A4 (ko) |
JP (3) | JP2019506435A (ko) |
KR (1) | KR20180112043A (ko) |
CN (1) | CN108883168A (ko) |
AU (1) | AU2017223970B2 (ko) |
BR (1) | BR112018067550A2 (ko) |
CA (1) | CA3015519A1 (ko) |
CL (1) | CL2018002438A1 (ko) |
CO (1) | CO2018009205A2 (ko) |
HK (1) | HK1256935A1 (ko) |
IL (1) | IL261340B2 (ko) |
MX (1) | MX2018010338A (ko) |
MY (1) | MY194694A (ko) |
SG (1) | SG11201807080UA (ko) |
WO (1) | WO2017147475A1 (ko) |
ZA (1) | ZA201805679B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021013069A1 (zh) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | 嵌合的人乳头瘤病毒11型l1蛋白 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024097051A1 (en) * | 2022-10-31 | 2024-05-10 | Pyrojas Inc. | Immunotherapy compositions and methods of use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890160A (zh) * | 2009-04-28 | 2010-11-24 | 北京康乐卫士生物技术有限公司 | 多价重组人乳头瘤病毒疫苗及其应用 |
CN102481378A (zh) * | 2009-04-13 | 2012-05-30 | 法国健康和医学研究院 | Hpv颗粒及其用途 |
CN102497880A (zh) * | 2009-06-25 | 2012-06-13 | 葛兰素史密丝克莱恩生物有限公司 | 新的人乳头状瘤病毒(hpv)蛋白构建体及其在预防hpv疾病中的用途 |
US20130064849A1 (en) * | 2011-07-14 | 2013-03-14 | The Board Of Regents Of The University Of Texas | Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
US8809562B2 (en) * | 2011-06-06 | 2014-08-19 | Chevron Phillips Chemical Company Lp | Use of metallocene compounds for cancer treatment |
US20150110824A1 (en) * | 2012-03-18 | 2015-04-23 | Glaxosmithkline Biologicals, Sa | Method of vaccination against human papillomavirus |
US20130251782A1 (en) * | 2012-03-22 | 2013-09-26 | Leo Laboratories Limited | Topical application of ingenol mebutate with occlusion |
US20140275082A1 (en) * | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
EP3054994A4 (en) * | 2013-10-13 | 2017-10-11 | The Board of Trustees of the University of Arkansas | Human papilloma virus therapeutic vaccine |
US10286058B2 (en) * | 2014-01-13 | 2019-05-14 | Baylor Research Institute | Vaccines against HPV and HPV-related diseases |
BR112017008280A2 (pt) * | 2014-10-24 | 2018-01-02 | Hpvvax, Llc. | método para o tratamento de um paciente |
-
2017
- 2017-02-24 MX MX2018010338A patent/MX2018010338A/es unknown
- 2017-02-24 AU AU2017223970A patent/AU2017223970B2/en active Active
- 2017-02-24 CN CN201780016785.3A patent/CN108883168A/zh active Pending
- 2017-02-24 KR KR1020187027123A patent/KR20180112043A/ko unknown
- 2017-02-24 JP JP2018544832A patent/JP2019506435A/ja active Pending
- 2017-02-24 MY MYPI2018001489A patent/MY194694A/en unknown
- 2017-02-24 BR BR112018067550A patent/BR112018067550A2/pt unknown
- 2017-02-24 CA CA3015519A patent/CA3015519A1/en active Pending
- 2017-02-24 EP EP17757336.7A patent/EP3419661A4/en active Pending
- 2017-02-24 WO PCT/US2017/019433 patent/WO2017147475A1/en active Application Filing
- 2017-02-24 SG SG11201807080UA patent/SG11201807080UA/en unknown
- 2017-02-24 CO CONC2018/0009205A patent/CO2018009205A2/es unknown
-
2018
- 2018-08-23 IL IL261340A patent/IL261340B2/en unknown
- 2018-08-24 CL CL2018002438A patent/CL2018002438A1/es unknown
- 2018-08-24 ZA ZA201805679A patent/ZA201805679B/en unknown
- 2018-12-13 HK HK18116062.9A patent/HK1256935A1/zh unknown
-
2021
- 2021-06-30 JP JP2021108667A patent/JP2021155448A/ja active Pending
-
2023
- 2023-06-05 JP JP2023092142A patent/JP2023110038A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102481378A (zh) * | 2009-04-13 | 2012-05-30 | 法国健康和医学研究院 | Hpv颗粒及其用途 |
CN101890160A (zh) * | 2009-04-28 | 2010-11-24 | 北京康乐卫士生物技术有限公司 | 多价重组人乳头瘤病毒疫苗及其应用 |
CN102497880A (zh) * | 2009-06-25 | 2012-06-13 | 葛兰素史密丝克莱恩生物有限公司 | 新的人乳头状瘤病毒(hpv)蛋白构建体及其在预防hpv疾病中的用途 |
US20130064849A1 (en) * | 2011-07-14 | 2013-03-14 | The Board Of Regents Of The University Of Texas | Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines |
Non-Patent Citations (2)
Title |
---|
ANNA TADDIO等: "A randomized controlled trial of analgesia during vaccination in adults", 《VACCINE 》 * |
明日科学网: "人类乳突病毒疫苗成功治疗皮肤癌", 《中国肿瘤临床与康复》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021013069A1 (zh) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | 嵌合的人乳头瘤病毒11型l1蛋白 |
Also Published As
Publication number | Publication date |
---|---|
CL2018002438A1 (es) | 2019-01-04 |
AU2017223970B2 (en) | 2022-01-27 |
KR20180112043A (ko) | 2018-10-11 |
EP3419661A4 (en) | 2019-10-23 |
ZA201805679B (en) | 2019-11-27 |
IL261340B1 (en) | 2023-03-01 |
IL261340A (en) | 2018-11-29 |
HK1256935A1 (zh) | 2019-10-04 |
MX2018010338A (es) | 2018-11-09 |
CA3015519A1 (en) | 2017-08-31 |
CO2018009205A2 (es) | 2018-09-20 |
IL261340B2 (en) | 2023-07-01 |
EP3419661A1 (en) | 2019-01-02 |
JP2021155448A (ja) | 2021-10-07 |
JP2023110038A (ja) | 2023-08-08 |
SG11201807080UA (en) | 2018-09-27 |
BR112018067550A2 (pt) | 2019-10-01 |
JP2019506435A (ja) | 2019-03-07 |
MY194694A (en) | 2022-12-15 |
WO2017147475A1 (en) | 2017-08-31 |
AU2017223970A1 (en) | 2018-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1953743B (zh) | 局部辅酶q10制剂及其使用方法 | |
ES2956509T3 (es) | Conjugados de montelukast y péptidos | |
JP2023110038A (ja) | ワクチンを使用して癌または皮膚病変を治療するための方法および組成物 | |
WO2019011286A1 (en) | ANTIVIRAL USE OF MEMBRANE ADHESIVE PROTEINS | |
WO2019214723A1 (zh) | 绿原酸及其组合物在制备治疗鳞状细胞癌的药物中的用途 | |
JP2018513130A (ja) | Hsp90阻害ペプチド結合体及びその腫瘍治療における応用 | |
TWI414304B (zh) | 使用茄屬植物的水溶性萃取物來治療疣 | |
US20220105082A1 (en) | New formulations containing leukotriene receptor antagonists | |
US10799574B2 (en) | Method and composition for treating cancer or skin lesion using a vaccine | |
US11813329B2 (en) | Method and composition for treating cancer or skin lesion using a vaccine | |
CN114588164A (zh) | 瑞马唑仑在预防围术期低体温和寒战中的应用 | |
US20230414741A1 (en) | Method and compositon for treating cancer using a vaccine | |
KR20220119051A (ko) | 신규한 다기능성 올리고펩타이드 | |
AU2021360676A1 (en) | Composition and method for treating cancer using a vaccine as a first therapueutic active ingredient in combination with a second active ingredient | |
EA020953B1 (ru) | Внутрикожная вакцина против гриппа | |
JP2021535197A (ja) | 疣贅の治療 | |
JP6663438B2 (ja) | 癌および皮膚病変の治療 | |
BR112020005695A2 (pt) | composição da vacina da hepatite b nasal e método para produzir a mesma | |
CN104940185B (zh) | 刺芒柄花素的医药用途 | |
EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
WO2022121884A1 (zh) | 伊维菌素及其类似物在皮肤相关疾病治疗中的应用 | |
CN104586823A (zh) | 老年斑/疣消除液 | |
WO2016107955A1 (es) | Uso de análogos del ión pirofosfato para el tratamiento de la infección por vph | |
TW201119646A (en) | Method for treating herpes virus infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1256935 Country of ref document: HK |